JRI (Nuveen Real Assetome and Growth Fund) 6-Month Price Index: 0.92 (As of Sep. 16, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

JRI Nuveen Real Asset Income and Growth Fund JRI
52 GF Score
Price $11.67
GF Value $15.11
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Nuveen Real Assetome and Growth Fund 6-Month Price Index?

Nuveen Real Assetome and Growth Fund JRI +0.43% 52 6-Month Price Index is 0.92 as of Sep. 16, 2026. GuruFocus rates JRI with a GF Score™ of 52/100 and a GF Value™ of $15.11 (Modestly Undervalued). The stock has 5 warning signs investors should review.

6-Month Price Index is an intermediate-term momentum that shows the price change relative to 6-month ago. It’s calculated by current share price divided by share price 6-months ago. As of today (2026-09-16), Nuveen Real Assetome and Growth Fund's 6-Month Price Index is 0.92.

Nuveen Real Assetome and Growth Fund  (NYSE:JRI) 6-Month Price Index Explanation

Price Index (PI) also called momentum. Strategies involving Price Index are also known as momentum strategies as they allow investors to profit from a company’s stock price. 6-Month Price Index is an intermediate-term momentum that shows the price change relative to 6-month ago.

The investment strategy for momentum investors is to buy winners and sell losers. That is, buy stocks that performed well and sell stocks that performed poorly in the past.

Nuveen Real Assetome and Growth Fund 6-Month Price Index Related Terms

JRI vs HPF, EMF, BKT: 6-Month Price Index Comparison

For the Asset Management subindustry, Nuveen Real Assetome and Growth Fund's 6-Month Price Index, along with its competitors' market caps and 6-Month Price Index data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

JRI
52GF Score
Nuveen Real Asset Income and Growth Fund JRI
6-Month Price Index is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nuveen Real Assetome and Growth Fund  (NYSE:JRI) 6-Month Price Index Calculation

6-Month Price Index is calculated as following:

6-Month Price Index=Current Share Price / Share Price 6-Months Ago

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about 6-Month Price Index →
What does a 6-Month Price Index of 0.92 mean?
Nuveen Real Assetome and Growth Fund (JRI) has a 6-Month Price Index of 0.92 as of Sep. 16, 2026. 6-Month Price Index is an intermediate-term momentum that shows the price change relative to 6-month ago. View historical data on Nuveen Real Assetome and Growth Fund and its competitors.
Is Nuveen Real Assetome and Growth Fund's 6-Month Price Index too high?
Nuveen Real Assetome and Growth Fund's current 6-Month Price Index is 0.92. Overall, Nuveen Real Assetome and Growth Fund has a GF Score™ of 52/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Nuveen Real Assetome and Growth Fund's 6-Month Price Index compare to HPF and EMF?
Nuveen Real Assetome and Growth Fund's 6-Month Price Index of 0.92 can be compared against companies in the Asset Management industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 6-Month Price Index for an Asset Management company?
A good 6-Month Price Index depends on the Asset Management industry context. However, 6-Month Price Index should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 6-Month Price Index mean?
A high 6-Month Price Index can signal that a stock is expensive relative to its fundamentals. 6-Month Price Index is an intermediate-term momentum that shows the price change relative to 6-month ago. View historical data on Nuveen Real Assetome and Growth Fund and its competitors. Nuveen Real Assetome and Growth Fund's current 6-Month Price Index is 0.92. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nuveen Real Assetome and Growth Fund stock overvalued right now?
Based on GuruFocus' analysis, Nuveen Real Assetome and Growth Fund (JRI) is currently considered Modestly Undervalued. The stock's GF Value™ is $15.11, compared to a current price of $11.67 — trading 22.8% below its estimated fair value. The current 6-Month Price Index is 0.92. Nuveen Real Assetome and Growth Fund's overall GF Score™ is 52/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 6-Month Price Index calculated?
6-Month Price Index is calculated from a company's financial statements. For Nuveen Real Assetome and Growth Fund (JRI), the current 6-Month Price Index is 0.92 as of Sep. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Nuveen Real Assetome and Growth Fund (JRI) Overvalued in 2026?

Based on GuruFocus' analysis, Nuveen Real Assetome and Growth Fund stock appears to be undervalued. The current stock price of $11.67 is trading 22.8% below its estimated GF Value™ of $15.11. GuruFocus considers Nuveen Real Assetome and Growth Fund to be Modestly Undervalued.

Key valuation signals for JRI:

  • 6-Month Price Index: 0.92
  • GF Value™: $15.11 vs. price of $11.67 (22.8% below fair value)
  • GF Score™: 52/100 with 5 warning signs

No single metric tells the full story. See the JRI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Nuveen Real Assetome and Growth Fund Business Description

Address 333 West Wacker Drive, Chicago, IL, USA, 60606
Nuveen Real Asset Income and Growth Fund is a closed-end fund. Its objective is to provide a high level of current income and long-term capital appreciation. The fund invests a majority of its managed assets in equity and debt securities issued by real asset related companies located anywhere in the world. Its plan involves investments in five security types, infrastructure common stock, REIT preferred stock and debt securities. Real asset-related companies include those engaged in owning, operating, or developing infrastructure projects, facilities, and services, as well as REITs.
52GF Score

Get the complete analysis for JRI

6-Month Price Index is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$11.67
Price
$15.11
GF Value